I recently had the opportunity to pick up a copy of Lee Lowell’s 2009 book Get Rich With Options: Four Winning Strategies Straight from the Exchange Floor. Lee wrote an excellent primer on options trading, but the publisher probably should have put a little more thought into the title. Get Rich With Options has very little to do with getting rich with options. Instead, it is a level-headed explanation of various low-risk options trading strategies that generate small, consistent profits over time. (Though to be fair, “Generate Small, Consistent Over Time With Options” doesn’t look quite as good in print.) For readers who are accu...
Shortly after testing resistance around the $3.08 level a couple weeks ago to open up September natural gas prices declined rather dramatically, with heavy selling coming initially after the holiday weekend and then heavier selling coming into last Friday as Irma approached Florida. Prices settled last week down at $2.89 support, logging one of the larger weekly losses in awhile. Prices bounced back somewhat today as damage from Irma did not appear quite as extreme as it appeared it could be, and this has further confirmed that some late-week selling last week was Irma-driven. Yet we believe some of the selling last week was seasonal in nat...
Regeneron Pharmaceuticals, Inc. (REGN – Free Report) and partner Sanofi (SNY – Free Report) announced that Dupixent (dupilumab) met its two primary endpoints in a phase III study conducted on patients with uncontrolled, persistent asthma. Data from the LIBERTY ASTHMA QUEST study showed that Dupixent, when added to standard therapies, reduced severe asthma attacks and improved lung function. Shares of Regeneron have outperformed the industry year to date. The stock has increased 28.4% as against the industry’s gain of 15.6% in the same time frame. Dupixent Injection is presently marketed in the United States for the treatme...
What a day for risk. USD/JPY rallied aggressively after trading at a 2017 low on Friday and the S&P 500 rose the most since April to close at all-time highs. Other risk-off markets like Gold gapped lower on the open and the US Treasury 10-year yield also bounced showing investors wanted risk over a fixed return. Things look good, at least for today. This week will provide a lot to chew on in terms of what lays ahead. A lot of focus in the FX has shifted to the UK and Canada. The UK is loaded with data this week. Tomorrow brings the CPI print, which could pressure the BoE into needing to hike rates despite concerns voiced by Carney o...
The Australian dollar reached new highs and seems more confident above 0.80. Where next? Is the bull trend in tact? Here is their view, courtesy of eFXnews: AUD/USD: Allow For S/T Selling Before Resuming Of Core Bull Trend: Levels & Targets – Credit Suisse Credit Suisse FX Technical Strategy Research notes that AUD/USD has held uptrend and price support at .7866 before breaking above the July high of .8067 and settling around there. “We allow for fresh selling here, but favor a break above to reinstate the core bull trend for .8163/67 initially, and eventually our core target of .8453/83,” On the downside, CS argues that a removal ...
Shares of consumer goods giant Procter & Gamble (PG) are up after Nelson Peltz and his Trian Fund spoke earlier at an investor conference to discuss the white paper that Trian released last week. TRIAN’S WHITE PAPER: On September 6, activist investor Trian, which has significant investments in General Electric Company (GE), Mondelez (MDLZ), BNY Mellon (BK), and Sysco (SYY), released a 93 page report, or white paper, on its perspective on how Trian and Peltz intend to help P&G regain market share and why it’s critical to have Nelson Peltz elected to the P&G board. Trian said that P&G’s total shareholder return...
Below is a chart of the S&P 500-tracking SPY ETF from our Interactive Chart Tool platform (use it for free at any time here). If current prices hold, the S&P will make a new all-time closing high today…eclipsing highs last made in early August. We’ve been covering underlying market breadth quite a bit over the last few weeks, and as shown below, as of this afternoon, 62% of stocks in the S&P 500 are above their 50-day moving averages. We realize the S&P 500 just made a new high today, but 62% is well below prior high points seen for this breadth measure over the last year. We’d like to see it more elevated when a ne...
In doing some research this past week, I came upon a thread encouraging readers to talk about their worst investment or stock trade they’ve ever been a part of. It was a fascinating read that reminded me of the one thing that most people don’t feel like talking about. And that is that everybody has losing investments. Everybody. Even the pros. I shared my worst trade on that thread and, in the spirit of having a little fun, I figure I’d share the story here as well! Around 1999 or 2000, right as the tech bubble was peaking, I bought stock in Internet Capital Group. It is (or was, the company has since transformed into cloud technology c...
Ok, well if you wanted to look at just one thing to gauge sentiment on Monday, USD/JPY would probably be just as good a choice as anything. Between the rebound in Treasury yields and the evaporation of the safe haven bid, multiple factors are weighing on the yen and USD/JPY is set for its biggest gain in at least eight months: Looks like spec positioning was correct on this one: Of course as Bloomberg’s Dennis Pettit notes, that’s assuming everyone had the intestinal fortitude to not only endure the pain through Friday, but also to hang onto those shorts over the weekend, because the positioning data is only current through early last ...